Theriault RL - Search Results

1

Daily oral etoposide in patients with heavily pretreated metastatic breast cancer.

Pusztai L, Walters RS, Valero V, Theriault RL, Hortobagyi GN. Pusztai L, et al. Among authors: theriault rl. Am J Clin Oncol. 1998 Oct;21(5):442-6. doi: 10.1097/00000421-199810000-00004. Am J Clin Oncol. 1998. PMID: 9781596 Clinical Trial.

2

Vertebral osteomyelitis mimicking bone metastasis in breast cancer patients.

Voravud N, Theriault R, Hortobagyi G. Voravud N, et al. Am J Clin Oncol. 1992 Oct;15(5):428-32. doi: 10.1097/00000421-199210000-00006. Am J Clin Oncol. 1992. PMID: 1524044

3

A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.

Wallerstein R Jr, Spitzer G, Dunphy F, Huan S, Hortobagyi G, Yau J, Buzdar A, Holmes F, Theriault R, Ewer M, et al. Wallerstein R Jr, et al. J Clin Oncol. 1990 Nov;8(11):1782-8. doi: 10.1200/JCO.1990.8.11.1782. J Clin Oncol. 1990. PMID: 2121909

4

Phase II study of deoxyspergualin in metastatic breast cancer.

Dhingra K, Valero V, Gutierrez L, Theriault R, Booser D, Holmes F, Buzdar A, Fraschini G, Hortobagyi G. Dhingra K, et al. Invest New Drugs. 1994;12(3):235-41. doi: 10.1007/BF00873965. Invest New Drugs. 1994. PMID: 7896543 Clinical Trial.

5

Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.

Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN. Dhingra K, et al. Clin Cancer Res. 1995 Jul;1(7):691-7. Clin Cancer Res. 1995. PMID: 9816034 Clinical Trial.

6

Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.

Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary SE, McNeese MD. Katz A, et al. J Clin Oncol. 2000 Aug;18(15):2817-27. doi: 10.1200/JCO.2000.18.15.2817. J Clin Oncol. 2000. PMID: 10920129

7

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN. Holmes FA, et al. Among authors: theriault rl. J Natl Cancer Inst. 1991 Dec 18;83(24):1797-805. doi: 10.1093/jnci/83.24.1797-a. J Natl Cancer Inst. 1991. PMID: 1683908 Clinical Trial.

8

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.

Buzdar AU, Kau SW, Hortobagyi GN, Ames FC, Holmes FA, Fraschini G, Hug V, Theriault RL, McNeese MD, Singletary SE. Buzdar AU, et al. Among authors: theriault rl. Cancer. 1992 Jan 15;69(2):448-52. doi: 10.1002/1097-0142(19920115)69:2<448::aid-cncr2820690229>3.0.co;2-k. Cancer. 1992. PMID: 1728373

9

Phase I-II study of high-dose etoposide in patients with refractory breast cancer.

Fraschini G, Holmes FA, Esparza L, Theriault RL, Buzdar AU, Hortobagyi GN. Fraschini G, et al. Among authors: theriault rl. Invest New Drugs. 1991 Nov;9(4):365-7. doi: 10.1007/BF00183583. Invest New Drugs. 1991. PMID: 1804815 Clinical Trial. No abstract available.

10

Pirarubicin in combination chemotherapy for metastatic breast cancer.

Hortobagyi GN, Theriault RL, Frye D, Walters RS, Fraschini G, Tashima CK, Ro JS, Salewski E, Buzdar AU. Hortobagyi GN, et al. Among authors: theriault rl. Am J Clin Oncol. 1990;13 Suppl 1:S54-6. doi: 10.1097/00000421-199012001-00012. Am J Clin Oncol. 1990. PMID: 2291460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page